229 related articles for article (PubMed ID: 27613833)
1. Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1.
Choi YJ; Shin HW; Chun YS; Leutou AS; Son BW; Park JW
Oncotarget; 2016 Sep; 7(38):62107-62122. PubMed ID: 27613833
[TBL] [Abstract][Full Text] [Related]
2. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
3. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
4. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
[TBL] [Abstract][Full Text] [Related]
5. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract][Full Text] [Related]
6. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
Park JJ; Hwang SJ; Park JH; Lee HJ
Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
[TBL] [Abstract][Full Text] [Related]
7. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
8. Shikonin suppresses proliferation and induces cell cycle arrest through the inhibition of hypoxia-inducible factor-1α signaling.
Li MY; Mi C; Wang KS; Wang Z; Zuo HX; Piao LX; Xu GH; Li X; Ma J; Jin X
Chem Biol Interact; 2017 Aug; 274():58-67. PubMed ID: 28684144
[TBL] [Abstract][Full Text] [Related]
9. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
[TBL] [Abstract][Full Text] [Related]
11. NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.
Kim KH; Kim D; Park JY; Jung HJ; Cho YH; Kim HK; Han J; Choi KY; Kwon HJ
J Mol Med (Berl); 2015 May; 93(5):499-509. PubMed ID: 25471482
[TBL] [Abstract][Full Text] [Related]
12. Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis.
Fu B; Xue J; Li Z; Shi X; Jiang BH; Fang J
Mol Cancer Ther; 2007 Jan; 6(1):220-6. PubMed ID: 17237281
[TBL] [Abstract][Full Text] [Related]
13. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
15. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
17. Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
Ma J; Li J; Wang KS; Mi C; Piao LX; Xu GH; Li X; Lee JJ; Jin X
Int Immunopharmacol; 2016 Oct; 39():1-9. PubMed ID: 27394002
[TBL] [Abstract][Full Text] [Related]
18. Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells.
Jung JE; Kim HS; Lee CS; Park DH; Kim YN; Lee MJ; Lee JW; Park JW; Kim MS; Ye SK; Chung MH
Carcinogenesis; 2007 Aug; 28(8):1780-7. PubMed ID: 17557905
[TBL] [Abstract][Full Text] [Related]
19. Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer.
Zhang YF; Zhang ZH; Li MY; Wang JY; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Zuo HX; Jin HL; Ma J; Jin X
Phytomedicine; 2021 Jan; 81():153425. PubMed ID: 33310309
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
